Differin Appears in 10.0% of AI Answers. Here's Our Five-Step Plan to Improve Its AI Visibility.
This report supports CiteWorks Studio's examination of how AI search is recommending Dermatologist Recommended Skin Care Brands. For more detail, you can also read Dermatologist Recommended Skin Care Brands: AI Visibility Discovery Index.
On this report
Browse sections
- Answer Capsule
- Current AI visibility
- What changed since last month
- Next Step
- Step 1. Measure
- Step 2. Make the website consistent
- Step 3. Align the external narrative
- Step 4. Optimize priority company pages
- Step 5. Publish around buyer questions
- Our 90-day action plan
- Methodology
- Our first three priorities
- Learn More
Key Takeaways
- Differin is mentioned in about one in ten benchmark answers, but it is recommended less often than it is named.
- Top-three and first-place placements are limited, showing weaker endorsement than recognition.
- No conflicting claims were recorded, so the first step is a scoped fact review rather than immediate corrections.
- Buyer questions and a single cited company page point to content briefs and page updates grounded in verified product facts.
Answer Capsule
In November 2026, Differin appeared in 77 of 773 AI answers included in the Dermatologist Recommended Skin Care Brands benchmark (9.96%). It received 41 recommendations (5.30%), with 7 Top 3 placements and 5 first-place recommendations. A mention means the company appeared in an answer; a recommendation means the answer affirmatively endorsed it.
Our plan compares the company with its competitors, checks conflicting AI claims against reliable sources, and identifies website pages, third-party sources and buyer questions to address. The historical results show how the figures changed across available months. Different monthly samples limit those comparisons, and conflicting AI claims require verification before corrections are proposed.
Current AI visibility
Questions This Section Answers
- How do Differin mentions, recommendations and placements compare with its Dermatologist Recommended Skin Care Brands peers?
Differin recorded 77 mentions (9.96%) and 41 recommendations (5.30%) across 773 answers included in the benchmark. Top 3 placements numbered 7; first-place recommendations numbered 5. Framing among its mentions was 43 positive, 34 neutral and 0 negative.
Rank | Company | Mentions | Mention rate | Recommendations | Recommendation rate | Top 3 | Top 3 rate | #1 | #1 rate |
|---|---|---|---|---|---|---|---|---|---|
1 | 757 | 97.93% | 582 | 75.29% | 342 | 44.24% | 244 | 31.57% | |
2 | 712 | 92.11% | 541 | 69.99% | 312 | 40.36% | 110 | 14.23% | |
3 | 583 | 75.42% | 427 | 55.24% | 168 | 21.73% | 57 | 7.37% | |
4 | 518 | 67.01% | 334 | 43.21% | 121 | 15.65% | 33 | 4.27% | |
5 | 442 | 57.18% | 242 | 31.31% | 76 | 9.83% | 18 | 2.33% | |
6 | 350 | 45.28% | 199 | 25.74% | 51 | 6.60% | 21 | 2.72% | |
7 | 250 | 32.34% | 153 | 19.79% | 38 | 4.92% | 21 | 2.72% | |
8 | 234 | 30.27% | 130 | 16.82% | 34 | 4.40% | 8 | 1.03% | |
9 | 248 | 32.08% | 128 | 16.56% | 41 | 5.30% | 17 | 2.20% | |
10 | Differin | 77 | 9.96% | 41 | 5.30% | 7 | 0.91% | 5 | 0.65% |
Differin appears in roughly one in ten benchmark answers, but it is recommended far less often than it is mentioned. That gap matters more than the raw mention count: being named alongside larger brands is not the same as being the brand an answer puts forward. The practical task is to understand what separates a mention from an endorsement.
Placement is thin as well. When Differin is recommended, it rarely lands near the top of an answer, and first-place appearances are rarer still. For a treatment-focused brand competing against mass-market cleansers and moisturizers, this suggests the brand is recognized but not the default pick. A visibility scorecard comparing Differin's placement pattern with the leading brands would give the client a clear starting point.
What changed since last month
Questions This Section Answers
- How did Differin counts and coverage differ across the available monthly snapshots?
Metric | Jul 2026 | Aug 2026 | Sep 2026 | Oct 2026 | Nov 2026 |
|---|---|---|---|---|---|
Mentions | 51 / 773 (6.60%) | 63 / 760 (8.29%) | 68 / 760 (8.95%) | 63 / 770 (8.18%) | 77 / 773 (9.96%) |
Recommendations | 47 / 773 (6.08%) | 54 / 760 (7.11%) | 60 / 760 (7.89%) | 58 / 770 (7.53%) | 41 / 773 (5.30%) |
Top 3 recommendations | 9 / 773 (1.16%) | 7 / 760 (0.92%) | 14 / 760 (1.84%) | 15 / 770 (1.95%) | 7 / 773 (0.91%) |
#1 recommendations | 1 / 773 (0.13%) | 3 / 760 (0.39%) | 1 / 760 (0.13%) | 2 / 770 (0.26%) | 5 / 773 (0.65%) |
From October 2026 to November 2026, Differin's mention count rose from 63 to 77, while its recommendation count fell from 58 to 41. The recommendation rate was 7.53% and 5.30% respectively.
The latest month shows mentions rising while recommendations fell. Those two movements are worth reading separately: the brand is being named more often, but fewer of those appearances carry an affirmative endorsement. The recommendation rate moved down over the same period, so the share of answers recommending Differin is smaller even as its name appears more.
Placement also softened after a stronger autumn. Top-three and first-place appearances were lower in the latest sample than in the two preceding months. Because each month is a separate sample of answers, the shift should be treated as an observed change rather than a trend with a known cause. The agency would track mentions, recommendations and placement as distinct measures in the baseline scorecard so future movement can be read without conflating them.
AI recommendation trend
Observed recommendation rate (%), Jul 2026 to Nov 2026
- Differin5.30%
Separate selected monthly samples. Missing points are unavailable, not zero. Provider/prompt equivalence is unverified; rate movement does not demonstrate causation.
/ Take the next step
Want to Understand Your AI Citation Footprint?
We start every engagement with a full audit of how AI systems reference your brand today.
Measurable, Repeatable Programme
Build a durable foundation of credible citations that compounds over time and continues to influence AI answers as new queries emerge
Citation Architecture Review
Identify which high-authority community sources are and aren't working in your favour across AI platforms.
AI Visibility Audit
Understand exactly how LLMs are referencing your brand today and which sources are shaping those answers.
Step 1. Measure
Questions This Section Answers
- What should the agency measure and verify first for Differin?
AI answers contained 0 conflicting claims about Differin: 0 critical, 0 high, 0 medium, 0 low. Of these, 0 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.
No conflicting claims about Differin were recorded in the captured answers, so there is no immediate fact-check queue to work through. That is a clean starting position, not a reason to skip verification. The useful next step is a scoped fact-review register that lists the claims an answer could plausibly make about the brand and records which ones have been checked against current primary sources.
A visibility comparison would sit alongside it. Seeing where Differin is mentioned but not recommended, and where competitors occupy the top slots, helps the client decide whether the priority is broader recognition or stronger endorsement. Both pieces of work are proposed, and neither depends on assuming an error has occurred.
Step 2. Make the website consistent
Questions This Section Answers
- Which recorded claim differences about Differin should be verified before proposed page edits?
No results are available for this part of the analysis.
Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.
This part of the analysis returned no results, so there are no disputed topics to resolve for Differin at present. The absence of findings is itself informative: it means no page brief should be written around an alleged conflict until one is documented. Proposing corrections without a verified claim would risk changing accurate content.
The agency would keep the review open rather than closed. If a disputed claim surfaces later, the first step is to confirm the entity, the date and the original source, since differing dates can make two accurate statements look contradictory. Only after that check would a page brief be drafted, and only for claims the client can confirm from primary evidence.
Step 3. Align the external narrative
Questions This Section Answers
- Which cited third-party pages are relevant to fact review for Differin?
Cited page selected for review | Citation appearances in all captured answers | Answers mentioning the company | Conflicting claims linked to this page |
|---|---|---|---|
https://shop.pharmaplus.co.ke/products/differin-daily-deep-cleanser-118ml | 2 | 1 | 0 |
https://lazada.com.ph/tag/differin-gel/ | 1 | 1 | 0 |
https://youtube.com/shorts/zIS8Qvxb2QU | 26 | 18 | 0 |
https://reddit.com/r/medicine/comments/1tplik2/dermatologists_on_here_favorite_sk_in_n_products/ | 23 | 9 | 0 |
https://dermstore.com/c/skin-care/medical-grade/ | 21 | 8 | 0 |
https://ulta.com/shop/dermatologist-recommended | 11 | 8 | 0 |
These pages were selected because they relate to the company in the captured answers. Their current contents still need checking before any correction request. A page linked to a conflicting claim is not necessarily its cause, and the same answer may contribute to more than one row.
The cited pages selected for review span retailer listings, a video, a forum thread and category pages. Citation frequency varies widely across them, but a citation does not show that a page shaped an answer, and none of these pages is linked to a conflicting claim about Differin. The current contents of each page still need checking before any request is considered.
The agency would review the most frequently cited pages first, confirm what they currently say about Differin, and separate pages the client can influence from those it cannot. Where a page is accurate, the outcome is a no-change decision recorded for the client. Where an evidence-backed update seems justified, the request would be framed around verified product facts rather than an assumption of publisher error.
Step 4. Optimize priority company pages
Questions This Section Answers
- Which observed Differin website pages should receive review briefs?
Company website page | Citation appearances in all captured answers | Benchmark answers citing the page | Recommending answers citing the page |
|---|---|---|---|
https://differin.com/shop/daily-oil-free-hydrating-cleanser/302990221084.html | 1 | 1 | 1 |
The company's website was cited 1 times across 1 distinct page addresses; the table shows 1 pages selected for review. Zeros in the answer columns mean no matching answers were recorded. A cited page is not automatically a page that accompanied a recommendation.
Only one Differin website page was cited in the captured answers, and it appeared in a single benchmark answer that also recommended the brand. That is a narrow base, so the priority is to make the existing page as useful as possible rather than to assume the site is under-cited. A cited page is not automatically the page that drove a recommendation.
The agency would prepare a page brief built on approved product facts and the questions buyers actually ask, then check existing coverage before proposing anything new. The brief would note what the page should clarify and which claims need sign-off, leaving the client to confirm details before any edit is made.
Step 5. Publish around buyer questions
Questions This Section Answers
- Which observed buyer questions support content briefs for Differin?
Question observed in the research | Benchmark answers to this question | Company mentions | Company recommendations |
|---|---|---|---|
What are the top 10 skin care products? | 2 | 2 | 2 |
best skin care products dermatologist | 2 | 2 | 2 |
What are the non-comedogenic products? | 2 | 2 | 1 |
What skincare products do dermatologists use? | 3 | 2 | 1 |
What are the 5 must have skin care products? | 1 | 1 | 1 |
What are the top 5 skincare products? | 2 | 1 | 1 |
What are the top ten best skincare products? | 2 | 1 | 1 |
What brand do dermatologists recommend? | 2 | 1 | 1 |
These are recorded answer observations, not search volume, verified demand, or proof of missing website content.
The recorded questions cluster around best-product lists, dermatologist preferences and non-comedogenic options. Differin was mentioned in answers to most of them and recommended in several, which suggests the brand is already part of the conversation rather than absent from it. These are answer observations, not search volume or proof that the website lacks content.
The agency would turn the strongest of these questions into buyer-content briefs, checking first whether the site already answers them well. Where coverage exists, the brief would focus on sharpening the answer; where it does not, a new page could be proposed. Either way, the content would be built around verified product facts and the way buyers phrase the question.
Our 90-day action plan
Questions This Section Answers
- How should the agency sequence the proposed Differin work and judge completion?
Period | Deliverable | Completion criterion |
|---|---|---|
Days 1–30 | Baseline scorecard, scoped fact-review register and page/source shortlist | Each record has an owner, evidence requirement and review status |
Days 31–60 | Approved page briefs and justified publisher requests | Separate confirmed edits, no-change decisions, requests and responses |
Days 61–90 | Buyer-content briefs and a fresh scorecard | Record work completed separately from measured answer outcomes and comparability limits |
The first month establishes the baseline: a visibility scorecard, a scoped fact-review register and a shortlist of pages and sources to examine. Each record needs an owner, an evidence requirement and a review status, so the client can see what has been checked and what remains open.
The second month turns confirmed findings into page briefs and, where justified, publisher requests. Confirmed edits, no-change decisions, requests and responses are recorded separately so the client can tell them apart. The third month adds buyer-content briefs and a fresh scorecard. Completed work is reported separately from measured answer outcomes, and no visibility gain is promised.
Methodology
Questions This Section Answers
- How are Differin answer metrics and citation populations defined?
This report covers 2026-11. The exact dates when the original AI answers were collected have not been verified. The visibility rates use 773 answers that met the benchmark's inclusion rules. A company is recommended only when the answer both endorses it and uses positive wording. Top 3 and first-place counts are part of those recommendations, not extra recommendations.
An answer can mention or recommend several companies, so company counts cannot be added to find the number of distinct answers. The net sentiment score is positive minus negative mentions, divided by all company mentions; it describes answer wording, not customer satisfaction.
The wider citation analysis covers 800 captured answers and 5811 appearances of cited URLs. Citation appearances across all captured answers differ from the number of benchmark answers citing a page and the number that also recommend a company. The current contents of cited pages and disputed company claims still need independent verification.
Monthly sample coverage:
Reporting month | Answers included | AI services covered | Services |
|---|---|---|---|
Jul 2026 | 773 | 6 | ChatGPT, Copilot, Gemini, Google AI Mode, Google AI Overviews, Perplexity |
Aug 2026 | 760 | 6 | ChatGPT, Copilot, Gemini, Google AI Mode, Google AI Overviews, Perplexity |
Sep 2026 | 760 | 6 | ChatGPT, Copilot, Gemini, Google AI Mode, Google AI Overviews, Perplexity |
Oct 2026 | 770 | 6 | ChatGPT, Copilot, Gemini, Google AI Mode, Google AI Overviews, Perplexity |
Nov 2026 | 773 | 6 | ChatGPT, Copilot, Gemini, Google AI Mode, Google AI Overviews, Perplexity |
The answer samples differ between months. These comparisons show how the recorded results changed; they do not establish why they changed.
The report covers a single month, and the exact dates the original answers were collected have not been verified. A company counts as recommended only when an answer endorses it with positive wording; top-three and first-place appearances sit inside those recommendations rather than adding to them. Answers can name several companies, so company counts do not sum to a number of distinct answers.
Monthly samples differ, so comparisons describe how recorded results moved, not why. Citation appearances across all captured answers are a different measure from benchmark answers citing a page. Page contents and any disputed claims still require independent verification.
Our first three priorities
The first priority is a visibility scorecard that keeps mentions, recommendations and placement separate, so the client can see where Differin is named but not endorsed. The second is a scoped fact-review register, opened even though no conflicting claims were recorded, so future claims have a place to be checked against primary sources.
The third is a page brief for the cited Differin page, built on approved facts and buyer questions, with existing coverage checked before any new content is proposed. Publisher review follows only where current page contents justify a request. Together these give the client verified groundwork before any outward-facing change.
/ Learn More
Understanding AI search visibility.
AI search experiences create answers by pulling information from many places online and summarizing it into a single response.
What Is AI Citation Intelligence?
What Is Citation Architecture?
What Is Generative Engine Optimization?
What Is AI Share of Voice?
Archived editions
Browse earlier published research snapshots for this article. The latest edition remains at the current URL.


